To evaluate is elevated serum triglyceride the strongest single indicator for the presence of metabolic syndrome in patients with type 2 diabetes.

Journal Title: IJSR-International Journal Of Scientific Research - Year 2017, Vol 6, Issue 9

Abstract

Background:- The metabolic syndrome (MS) is described as clusters of abnormalities including abdominal obesity, insulin resistance, hypertension , hyperglycemia , increased triglycerides and decreased high density lipoprotein cholesterol (HDL-C)1. Patients with diabetes have metabolic syndrome with estimated prevalence of 69.9 per cent for whites, 64.8 percent for blacks, and 62.4 percent for Mexican Americans. Material and Methods:- The study was cross sectional. A total of 384 type II DM patients among these 384 patients males were 203 (52.86%) aged 46-66 years and females were 181 (47.14%) aged 45-65 years were enrolled in the study. Blood Pressure , serum lipid profile , waist circumference were measured in this study. Glycated hemoglobin (HbA1c) test was used to confirm Type II DM among the new cases. Metabolic syndrome was diagnosed using modified National educational program adult treatment panel-III NCEP ATP-III criteria. Result :- Among 384 diabetic patients, metabolic syndrome was present in 280 patients. The incidence was highest in 50-60 year's age group and lowest in 31-40 years age group. Metabolic syndrome was predicted highest by Triglycerides (62.14% patients,47% male & 53% females ) followed by HDL (61%) and than by Hypertension (60%). Sex wise analysis of data shows that HDL in female (48%) and hypertension in males (30%) was strongest predictor indicators of MS in type II DM. Conclusion:- Based on this study we find that triglyceride, hypertension and HDL together can be used as predictor for MS in type II DM, out of these three serum triglyceride may be considered as the strongest single predictor of MS in type II DM where as HDL in female and hypertension in males may be used as strongest predictors of MS in type II DM.

Authors and Affiliations

Dr. Sudhir Bhandari, Dr. Dilip Nagarwal, Dr. Jaswant Goyal, Dr. Barkha Goyal, Dr. Purva Sharma

Keywords

Related Articles

MODE OF ACTION OF VIRECHANA IN MIGRAINE – A CONCEPTUAL STUDY

Ardhavbhedaka is a type of shirashoola which is explained by all acharyas. According to sushrutha headache which is present in the right or left side of the head, which is splitting, pricking or churning in nature and ap...

A SINGLE CASE STUDY ON VELOCARDIAL FACIAL SYNDROME(VCFS)

Velocardiofacial Syndrome(VCFS) is a genetic condition characterized by abnormal pharyngeal arch development. The general Characteristics of VCFS include cleft lip palate (CLP) usually of the soft palate, heart problems,...

CLASSIFICATION OF EPILEPSIES AND EPILEPTIC SYNDROMES USING INTERNATIONAL LEAGUE AGAINST EPILEPSY 2010: A HOSPITAL BASED STUDY FROM RURAL POPULATION OF NORTH INDIA.

Objectives: To determine the distribution of various epilepsies and epileptic syndromes in the people with epilepsy (PWE) in view of limited published data from rural population of India. Material and Methods: A cross se...

A Study of Hypertension With Reference To Socioeconomic and Demographic Factors in Age Group of 30 To 50 Years of Age in An Urban Slum of Mumbai

Hypertension is a chronic condition of concern due to its role in the causation of coronary heart disease, stroke and other vascular complications. Objective was to study socioeconomic and demographic factors associated...

USE OF PAPER PATCHING AND TINCTURE FERRI PERCHLORIDE FOR DAY CARE MANAGEMENT OF TYMPANIC MEMBRANE PERFORATION

INTRODUCTION: Perforation of tympanic membrane constitutes a major portion of patients attending ENT OPD for which they are advised surgical procedures. Most of the cases with small perforations can be managed by doing O...

Download PDF file
  • EP ID EP512970
  • DOI -
  • Views 48
  • Downloads 0

How To Cite

Dr. Sudhir Bhandari, Dr. Dilip Nagarwal, Dr. Jaswant Goyal, Dr. Barkha Goyal, Dr. Purva Sharma (2017). To evaluate is elevated serum triglyceride the strongest single indicator for the presence of metabolic syndrome in patients with type 2 diabetes.. IJSR-International Journal Of Scientific Research, 6(9), 47-48. https://europub.co.uk/articles/-A-512970